✦ LIBER ✦

The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B

✍ Scribed by Shouval, Daniel

Book ID: 122474021
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 268 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2014.03.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Entecavir vs. lamivudine in chronic hepa

Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation

✍ Chen, Chien-Hung; Lin, Chih-Lang; Hu, Tsung-Hui; Hung, Chao-Hung; Tseng, Po-Lin; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 810 KB

The effect of lamivudine therapy in hepa

The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B

✍ Rong-Nan Chien; Chia-Hsien Lin; Yun-Fan Liaw 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Lamivudine monotherapy for spontaneous s

Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B

✍ AKIHITO TSUBOTA; YASUJI ARASE; YOSHIYUKI SUZUKI; FUMITAKA SUZUKI; HITOMI SEZAKI; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Lamivudine Therapy in the Treatment of C

Lamivudine Therapy in the Treatment of Chronic Hepatitis B with Acute Exacerbation During Pregnancy

✍ Jeng-Hsiu Hung; Chi-Jen Chu; Pi-Lin Sung; Chih-Yao Chen; Kuan-Chong Chao; Ming-J 📂 Article 📅 2008 🏛 Elsevier Science 🌐 Chinese ⚖ 168 KB

Efficacy of entecavir in patients with c

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone

✍ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/

Rhabdomyolytic syndrome during the lamiv

Rhabdomyolytic syndrome during the lamivudine therapy for acute exacerbation of chronic type B hepatitis

✍ Kaichiro Yahagi; Yoshiyuki Ueno; Yutaka Mano; Tooru Shimosegawa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB